Skip to main content
SpringerLink
Log in

Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

A Comment to this article was published on 14 September 2022

The Original Article was published on 28 August 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. Nielsen SW, Ruhlmann CH, Eckhoff L, Brønnum D, Herrstedt J, Dalton SO (2022) Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences. Support Care Cancer 30(2):1181–1190

    Article  PubMed  Google Scholar 

  2. Malhotra P, Casari I, Falasca M (2021) Therapeutic potential of cannabinoids in combination cancer therapy. Adv Biol Regul 79:100774

    Article  CAS  PubMed  Google Scholar 

  3. Jeffers AM, Glantz S, Byers A, Keyhani S (2021) Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US. JAMA Netw Open 4(11):e2136571

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gregus AM, Buczynski MW (2020) Druggable targets in endocannabinoid signaling. Adv Exp Med Biol 1274:177–201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kaur S, Sharma N, Roy A (2021) Role of cannabinoids in various diseases: a review. Curr Pharm Biotechnol. https://doi.org/10.2174/1389201023666211223164656

    Article  Google Scholar 

  6. Meng H, Page MG, Ajrawat P et al (2021) Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients. Can J Anaesth 68(5):633–644

    Article  CAS  PubMed  Google Scholar 

  7. Dryburgh LM, Bolan NS, Grof CPL et al (2018) Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol 84(11):2468–2476

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vitetta L, Sikali JF (2021) Comment on: Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in patients with chronic pain. Can J Anaesth 68(11):1707–1708

    Article  PubMed  Google Scholar 

  9. Hammond D (2021) Communicating THC levels and “dose” to consumers: implications for product labelling and packaging of cannabis products in regulated markets. Int J Drug Policy 91:102509

    Article  PubMed  Google Scholar 

  10. Pusiak RJ, Cox C, Harris CS (2021) Growing pains: an overview of cannabis quality control and quality assurance in Canada. Int J Drug Policy 93:103111

    Article  PubMed  Google Scholar 

  11. Weiss GA, Hennet T (2017) Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci 74(16):2959–2977

    Article  CAS  PubMed  Google Scholar 

  12. Meier MH, Caspi A, Ambler A et al (2012) Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 109(40):E2657-2664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Goldenberg M, Danovitch I, IsHak WW (2014) Quality of life and smoking. Am J Addict 23(6):540–562

    Article  PubMed  Google Scholar 

  14. Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS (2021) The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. J Natl Cancer Inst Monogr 2021(58):86–98

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Luis Vitetta & Jason F. Sikali

  2. Research Department, Medlab Clinical, Sydney, Australia

    Luis Vitetta, Jason F. Sikali, Courtney Fletcher & Jeremy D. Henson

  3. Prince of Wales Clinical School, The University of New South Wales, Sydney, Australia

    Jeremy D. Henson

Authors
  1. Luis Vitetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jason F. Sikali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Courtney Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeremy D. Henson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LV wrote the original draft of the manuscript; JFS, CF, JDH reviewed the manuscript. All authors agreed to the final version.

Corresponding author

Correspondence to Luis Vitetta.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vitetta, L., Sikali, J.F., Fletcher, C. et al. Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences. Support Care Cancer 30, 8619–8621 (2022). https://doi.org/10.1007/s00520-022-06995-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-022-06995-7

Keywords

Search

Navigation